Literature DB >> 29254938

Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry.

Shengfeng Wang1,2, Yonglan Zheng2, Temidayo O Ogundiran3, Oladosu Ojengbede4, Wei Zheng5, Katherine L Nathanson6, Barbara Nemesure7, Stefan Ambs8, Olufunmilayo I Olopade9, Dezheng Huo9,10.   

Abstract

Background: Pancreatic cancer mutation signatures closely resemble breast cancer, suggesting that both cancers may have common predisposition mechanisms that may include commonly inherited SNPs.
Methods: We examined 23 genetic variants known to be associated with pancreatic cancer as breast cancer risk factors in the Root genome-wide association study (GWAS; 1,657 cases and 2,029 controls of African diaspora) and GAME-ON/DRIVE GWAS (16,003 cases and 41,335 controls of European ancestry).
Results: None of the pancreatic cancer susceptibility variants were individually associated with breast cancer risk after adjustment for multiple testing (at α = 0.002) in the two populations. In Root GWAS, a change by one SD in the polygenic risk score (PRS) was not significantly associated with breast cancer. In addition, we did not observe a trend in the relationship between PRS percentiles and breast cancer risk.Conclusions: The association between reported pancreatic cancer genetic susceptibility variants and breast cancer development in women of African or European ancestry is likely weak, if it does exist.Impact: Known GWAS-derived susceptibility variants of pancreatic cancer do not explain its shared genetic etiology with breast cancer. Cancer Epidemiol Biomarkers Prev; 27(1); 116-8. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29254938      PMCID: PMC6644034          DOI: 10.1158/1055-9965.EPI-17-0755

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

1.  Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.

Authors:  Dezheng Huo; Ye Feng; Stephen Haddad; Yonglan Zheng; Song Yao; Yoo-Jeong Han; Temidayo O Ogundiran; Clement Adebamowo; Oladosu Ojengbede; Adeyinka G Falusi; Wei Zheng; William Blot; Qiuyin Cai; Lisa Signorello; Esther M John; Leslie Bernstein; Jennifer J Hu; Regina G Ziegler; Sarah Nyante; Elisa V Bandera; Sue A Ingles; Michael F Press; Sandra L Deming; Jorge L Rodriguez-Gil; Katherine L Nathanson; Susan M Domchek; Timothy R Rebbeck; Edward A Ruiz-Narváez; Lara E Sucheston-Campbell; Jeannette T Bensen; Michael S Simon; Anselm Hennis; Barbara Nemesure; M Cristina Leske; Stefan Ambs; Lin S Chen; Frank Qian; Eric R Gamazon; Kathryn L Lunetta; Nancy J Cox; Stephen J Chanock; Laurence N Kolonel; Andrew F Olshan; Christine B Ambrosone; Olufunmilayo I Olopade; Julie R Palmer; Christopher A Haiman
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150

Review 2.  Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.

Authors:  Evelina Mocci; Roger L Milne; Elena Yuste Méndez-Villamil; John L Hopper; Esther M John; Irene L Andrulis; Wendy K Chung; Mary Daly; Saundra S Buys; Nuria Malats; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254

3.  Association of breast cancer susceptibility variants with risk of pancreatic cancer.

Authors:  Fergus J Couch; Xianshu Wang; Robert R McWilliams; William R Bamlet; Mariza de Andrade; Gloria M Petersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

4.  Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.

Authors:  Siân Jones; Ralph H Hruban; Mihoko Kamiyama; Michael Borges; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Emily Palmisano; Kieran Brune; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; Giovanni Parmigiani; Scott E Kern; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Michael Goggins; Alison P Klein
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

5.  ATM mutations in patients with hereditary pancreatic cancer.

Authors:  Nicholas J Roberts; Yuchen Jiao; Jun Yu; Levy Kopelovich; Gloria M Petersen; Melissa L Bondy; Steven Gallinger; Ann G Schwartz; Sapna Syngal; Michele L Cote; Jennifer Axilbund; Richard Schulick; Syed Z Ali; James R Eshleman; Victor E Velculescu; Michael Goggins; Bert Vogelstein; Nickolas Papadopoulos; Ralph H Hruban; Kenneth W Kinzler; Alison P Klein
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

6.  The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog).

Authors:  Jacqueline MacArthur; Emily Bowler; Maria Cerezo; Laurent Gil; Peggy Hall; Emma Hastings; Heather Junkins; Aoife McMahon; Annalisa Milano; Joannella Morales; Zoe May Pendlington; Danielle Welter; Tony Burdett; Lucia Hindorff; Paul Flicek; Fiona Cunningham; Helen Parkinson
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

7.  Quantifying the Genetic Correlation between Multiple Cancer Types.

Authors:  Sara Lindström; Hilary Finucane; Brendan Bulik-Sullivan; Fredrick R Schumacher; Christopher I Amos; Rayjean J Hung; Kristin Rand; Stephen B Gruber; David Conti; Jennifer B Permuth; Hui-Yi Lin; Ellen L Goode; Thomas A Sellers; Laufey T Amundadottir; Rachael Stolzenberg-Solomon; Alison Klein; Gloria Petersen; Harvey Risch; Brian Wolpin; Li Hsu; Jeroen R Huyghe; Jenny Chang-Claude; Andrew Chan; Sonja Berndt; Rosalind Eeles; Douglas Easton; Christopher A Haiman; David J Hunter; Benjamin Neale; Alkes L Price; Peter Kraft
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

  7 in total
  2 in total

1.  Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer.

Authors:  Qing Wang; Jianzhong Ye; Daiqiong Fang; Longxian Lv; Wenrui Wu; Ding Shi; Yating Li; Liya Yang; Xiaoyuan Bian; Jingjing Wu; Xianwan Jiang; Kaicen Wang; Qiangqiang Wang; Mark P Hodson; Loïc M Thibaut; Joshua W K Ho; Eleni Giannoulatou; Lanjuan Li
Journal:  BMC Microbiol       Date:  2020-04-23       Impact factor: 3.605

Review 2.  Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review.

Authors:  Howard Lopes Ribeiro Junior; Lázaro Antônio Campanha Novaes; José Guilherme Datorre; Daniel Antunes Moreno; Rui Manuel Reis
Journal:  Curr Oncol       Date:  2022-08-04       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.